Studying colon surgery in retroperitoneal sarcoma patients
Part of Cancer clinical trials.
This study looks at people with rare abdominal sarcomas who also had part of their colon removed during surgery. It aims to understand how these combined surgeries affect outcomes, helping doctors better care for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of retroperitoneal sarcoma (a rare tumor in the back of your abdomen).
- Your surgery must have removed both the tumor and part of your colon or rectum (colorectal resection).
- The surgery must have taken place at a certified sarcoma center (or a hospital meeting the same standards).
- You must be 18 years old or older.
- You must give written permission (consent) to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults who have had surgery for a retroperitoneal sarcoma. It collects clinical and imaging information after treatment to better understand outcomes and guide future care.
This trial studies whether adding chemotherapy before surgery helps people with high-risk retroperitoneal (abdominal-area) leiomyosarcoma or liposarcoma. The goal is to improve outcomes while comparing surgery alone versus surgery plus neoadjuvant chemotherapy.
This study tests whether a short course of radiation before surgery can treat retroperitoneal sarcoma (a rare cancer in the back of the belly). It is for people whose tumor is removable and who have not had previous radiation in the same area.
This trial compares two different schedules of follow-up scans after surgery for retroperitoneal sarcoma. The goal is to see if less frequent scanning is just as safe and effective as more frequent scanning.
This trial is for people with a newly diagnosed soft tissue sarcoma that has not spread. It will study how surgery, physical therapy, and nutrition affect your recovery and quality of life.
This study is looking at genetic risk factors in people with retroperitoneal liposarcoma who are having surgery to remove the tumor. The goal is to understand how genes affect the disease and possibly guide future treatments.
Hear when a new Retroperitoneal Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.